Enteroviral Pathogenesis of Type 1 Diabetes

被引:0
|
作者
Hober, Didier [1 ]
Sane, Famara [1 ]
机构
[1] Univ Lille 2, CHRU Lille, EA3610, Lab Virol,Fac Med,Inst Hippocrate, F-59120 Loos Lez Lille, France
关键词
BLOOD MONONUCLEAR-CELLS; COXSACKIEVIRUS B4; RISK-FACTOR; BETA-CELLS; DEPENDENT ENHANCEMENT; PANCREATIC-ISLETS; INTERFERON-ALPHA; PROTEIN VP4; ANTIBODIES; INFECTION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Type 1 diabetes (T1D) is an autoimmune disease characterized by the disturbance of pancreatic insulin-producing cells, which results in hyperglycemia. The disease is associated with severe complications that impair the quality of life of individuals. The cause of T1D is unknown. Development of the disease is the result of interactions between immunological, genetic, and environmental factors. Viruses are thought to play an important role in the initiation or acceleration of the disease. This is an important issue since it opens the possibility to develop new preventive and therapeutic strategies to fight the disease. The role of enteroviruses in the development of T1D, in particular type B coxsackieviruses, is supported by epidemiological observations. It has been demonstrated that enterovirus infections were significantly more common in recently diagnosed diabetic patients, compared with control subjects. Enteroviral RNA and/or proteins can be detected in blood samples and intestine biopsies of patients with T1D. The hypothesis of a relationship between enteroviruses and the disease has been strengthened by the presence of enteroviral components or infectious particles in the pancreas of patients with T1D. In this review, arguments in favor of a relationship between enterovirus infections and T1D and the mechanisms of the enteroviral pathogenesis of the disease are presented. [Discovery Medicine 10(51):151-160, August 2010]
引用
收藏
页码:151 / 160
页数:10
相关论文
共 50 条
  • [41] Neuronal elements in the pathogenesis of Type 1 diabetes
    Tsui, H
    Winer, S
    Jakowsky, G
    Dosch, HM
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2003, 4 (03): : 301 - 310
  • [42] HIGHLIGHTS IN THE MOLECULAR PATHOGENESIS OF TYPE 1 DIABETES
    Kahraman, Sevim
    Dirice, Ercument
    Balci, Mustafa K.
    Omer, Abdulkadir
    Sanlioglu, Salih
    Sanlioglu, Ahter D.
    IUBMB LIFE, 2009, 61 (03) : 324 - 325
  • [43] The heterogeneous pathogenesis of type 1 diabetes mellitus
    Ilonen, Jorma
    Lempainen, Johanna
    Veijola, Riitta
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (11) : 635 - 650
  • [44] Innate immunity and the pathogenesis of type 1 diabetes
    Grieco, Fabio Arturo
    Vendrame, Francesco
    Spagnuolo, Isabella
    Dotta, Francesco
    SEMINARS IN IMMUNOPATHOLOGY, 2011, 33 (01) : 57 - 66
  • [45] Enteroviral infections and progression from islet autoimmunity to type 1 diabetes: The DAISY study
    Sosenko, J.
    Raykin-Mervis, L.
    Mahon, J.
    Lachin, J.
    Krause-Steinrauf, H.
    Krischer, J.
    Cuthbertson, D.
    Palmer, J.
    Skyler, J.
    ACTA DIABETOLOGICA, 2007, 44 : S50 - S51
  • [46] Type 1 Diabetes: Interferons and the Aftermath of Pancreatic Beta-Cell Enteroviral Infection
    Akhbari, Pouria
    Richardson, Sarah J.
    Morgan, Noel G.
    MICROORGANISMS, 2020, 8 (09) : 1 - 18
  • [47] Pancreatic islet expression of enteroviral receptors and dsRNA sensors in human type 1 diabetes
    Spagnuolo, I.
    Richardson, S. J.
    Sebastiani, G.
    Mancarella, F.
    Patti, A.
    Morgan, N. G.
    Dotta, F.
    DIABETOLOGIA, 2013, 56 : S139 - S140
  • [48] The role of CBR1 in the pathogenesis of type 1 diabetes
    Bang-Berthelsen, C.
    Bergholdt, R.
    Heding, P.
    Nerup, J.
    Pociot, F.
    DIABETOLOGIA, 2006, 49 : 254 - 255
  • [49] Cellular and molecular pathogenesis of type 1A diabetes
    M. M. Jahromi
    G. S. Eisenbarth
    Cellular and Molecular Life Sciences, 2007, 64
  • [50] Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
    Michelle Rosenzwajg
    Guillaume Churlaud
    Agnès Hartemann
    David Klatzmann
    Current Diabetes Reports, 2014, 14